By Helena Smolak
Royal Philips is scheduled to report results for the first quarter on Tuesday. Here is what you need to know.
SALES FORECAST: The Dutch health-technology company is expected to post 4.02 billion euros ($4.54 billion) in first-quarter sales, according to a company-compiled consensus, against 4.14 billion euros in the same prior-year period.
ADJUSTED EBITA FORECAST: Philips's adjusted earnings before interest, taxes and amortization is expected at 309 million euros by consensus for the quarter compared to 388 million euros last year.
NET INCOME FORECAST: Analysts estimate that the Amsterdam-listed group will report 19 million euros in first-quarter net income attributable to shareholders--compared with a net loss of 999 million euros in the first quarter of 2024.
As of Friday's market close in Europe, the stock fell 6.9% since the start of 2025.
WHAT TO WATCH
--China: Royal Philips will likely see a sales decline in China in the quarter due to uncertain market conditions on subdued demand for both consumer and health systems in the country, Jefferies and Morgan Stanley analysts said in a note. ING analysts expect a slow start to the year as Philips guided that growth will be back-end loaded.
--Tariffs: Morgan Stanley analysts see higher risks on potential tariff exposure for products in Royal Philips's consumer categories such as electric toothbrushes and razors compared with other of its medtech categories.
Write to Helena Smolak at helena.smolak@wsj.com
(END) Dow Jones Newswires
May 02, 2025 12:53 ET (16:53 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。